Adjusted EBITDA: Flat year on year at constant currencies. Organic Sales: Flat with a 2% positive price/mix offset by a 2% volume decline. OpEx: Flat year on year despite wage and general cost inflation. Adjusted Leverage Ratio: 2.8 times. Bond Issuance: EUR500 million 10-year bond at 4% issued in March. Volumes: Down 2%, with a 1% reduction excluding Turkey's timing effect. Adjusted EBITDA Margin: 13.7% at group level. Operating Working Capital: Flat at 18% of revenue. Free Cash Flow: Negative EUR183 million due to seasonality. Full-Year Guidance: Adjusted EBITDA above EUR1.55 billion at constant currency. Warning! GuruFocus has detected 7 Warning Signs with AKZOF. Release Date: April 23, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Akzo Nobel NV (AKZOF) delivered better-than-expected results in Q1 2025, with adjusted EBITDA flat year on year at constant currencies. The company successfully implemented over 70% of its targeted 2,200 SG&A reductions, ahead of schedule. Akzo Nobel NV (AKZOF) issued a EUR500 million 10-year bond at 4% in March, securing long-term funding at attractive terms. The company continues to gain market share in Powder, Marine, and Protective segments despite softer markets. Akzo Nobel NV (AKZOF) has localized procurement and production, reducing its reliance on China and mitigating tariff impacts. Negative Points Q1 reported volumes were down 2%, with a significant impact from the timing effect of commercial rebalancing in Turkey. Foreign exchange movements were a 1% headwind to revenue, mainly driven by the Turkish lira, Brazilian real, and Argentinian peso. The adjusted leverage ratio increased to 2.8 times due to seasonal working capital buildup and ongoing restructuring activities. The company faces macroeconomic volatility, creating an uncertain demand environment, particularly in North America. Vehicle Refinish and Automotive segments experienced softness, with no signs of immediate recovery. Q & A Highlights Q: On net pricing, is the 2% increase in Q1 a full contribution, or is there more pricing to come? Also, how is the raw material cost picture changing given the lower oil price? A: (Greg Poux-Guillaume, CEO) We have additional price increases planned beyond Q1, so more pricing will come throughout the year. Regarding raw materials, about half of our basket is correlated to oil. While the environment will likely be more beneficial than initially planned, any positive effects will be seen later in the year, primarily in Q3 and Q4. Story Continues Q: Could you provide an update on the Southeast Asian strategic review? Are there any potential delays or risks associated with transactions? A: (Greg Poux-Guillaume, CEO) Discussions are ongoing, and our focus is on finding the best outcome for AkzoNobel and our local business. We aim to conclude in Q2, and there are no changes to our plans despite market uncertainties. Q: How is the organization responding to the cost restructuring and industrial efficiency measures? A: (Greg Poux-Guillaume, CEO) The organization understands the necessity of these measures. We've communicated extensively, and while it's painful for individuals, it's seen as needed and positive for AkzoNobel. We are executing these measures quickly and fairly. Q: Why has Akzo maintained its expectations for flat to low single-digit volume growth this year despite macro risks? A: (Maarten de Vries, CFO) We came in slightly better than expected in Q1. While there is demand uncertainty, we are focused on efficiency measures. If volume softness occurs, we will double down on cost-saving measures. Q: Are there any changes to your plant closure plans due to tariffs or the new tariff world order? A: (Greg Poux-Guillaume, CEO) We are not re-evaluating our plant closures. Our localization efforts and procurement strategies have derisked our operations, and the closures will proceed as planned. The focus is on executing our current plans. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. View Comments
Akzo Nobel NV (AKZOF) Q1 2025 Earnings Call Highlights: Resilient Performance Amid Market Challenges
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...